Adage Capital Partners’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-550,000
Closed -$98.9M 789
2017
Q3
$98.9M Buy
+550,000
New +$76.6M 0.24% 112

Adage Capital Partners's KITE Position: Q4 2017 in Review

Adage Capital Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 550,000 shares — an estimated $98.9M sold.

Adage Capital Partners first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $98.9M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Adage Capital Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Adage Capital Partners sold 550,000 Kite Pharma, Inc. shares in Q4 2017, an estimated $98.9M.
  • Adage Capital Partners first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Adage Capital Partners's Kite Pharma, Inc. position peaked at $98.9M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Adage Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.